Showing results (1511-1520 of 1,764) with videos related to
Sort By:
Pageof 177
European Journal of Medicinal Chemistry|February 24, 2023
Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase 12 inhibitors in cancersTingyu Wen, Jun Wang, Ruiqiang Lu, et al.Nature Medicine|July 5, 2024
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trialHongnan Mo, Yongpei Yu, Xiaoying Sun, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 26, 2023
The regulation of tolerogenic dendritic cells by a Chinese herb formula improves abortion prone in miceFei Ma, Xiaoyang Feng, Erfeng Wang, et al.Breast (Edinburgh, Scotland)|September 24, 2023
Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trialMaiyue He, Jiaxuan Liu, Zijing Wang, et al.Journal of Alzheimer'S Disease : JAD|February 18, 2022
FOXG1 as a Potential Therapeutic Target for Alzheimer's Disease with a Particular Focus on Cell Cycle RegulationJia Wang, Si-Fei Ma, Qi Yun, et al.Breast Cancer Research and Treatment|May 13, 2020
Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancerFeng Du, Wenmiao Wang, Yongsheng Wang, et al.European Journal of Nutrition|March 6, 2025
Association of whole blood multi-micronutrients with mild cognitive impairment in Chinese older adults: a matched case-control studyZehao Wang, Cheng Cheng, Huilian Duan, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|November 30, 2013
Traditional chinese medicine tang-luo-ning ameliorates sciatic nerve injuries in streptozotocin-induced diabetic ratsDa-Wei Zou, Yan-Bin Gao, Zhi-Yao Zhu, et al.Theranostics|July 21, 2020
Melatonin ameliorates necrotizing enterocolitis by preventing Th17/Treg imbalance through activation of the AMPK/SIRT1 pathwayFei Ma, Hu Hao, Xiaoyan Gao, et al.BMC Cancer|July 22, 2024
Neoadjuvant inetetamab and pertuzumab with taxanes and carboplatin (TCbIP) In locally advanced HER2-positive breast cancer: a prospective cohort study with propensity-matched analysisMingxia Jiang, Yue Chai, Jiaxuan Liu, et al.Pageof 177